Biomedicine & Pharmacotherapy · 2019 · 76 citations · 28 references
MedicineCancer BiologyOncologyCarcinogenesisMetastasisMolecular OncologyLung CancerLung MetastasisMicrorna BiologyMicrorna-mediated RegulationOncogenic Signaling PathwaysTumor Suppressor GenesLung CarcinogenesisMicrorna Function In CancerMicrorna In CancerNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentOncogenic TransformationPten SignalingRecurrence
Lung cancer is the leading cause in all cancer deaths. A low survival rate and high recurrence rate of lung cancer make the endeavor to identify new, more effective therapies a primary goal. MicroRNAs (miRNAs) are regarded as regulators of tumorigenesis and it is known that miR-183-5p is significantly upregulated in non-small cell lung cancer (NSCLC), suggesting it has an oncogenic function in lung cancer. In this study, we found that miR-183-5p could promote lung carcinogenesis by directly targeting phosphatase tensin (PTEN). Further experiments indicated that miR-183-5p could suppress p53 and activate AKT signaling through phosphorylation. Moreover, our data indicated that miR-183-5p promoted tumor metastasis and tumor growth in vivo. Collectively, these results showed that miR-183-5p is required for NSCLC development through the suppressing PTEN, and might be a promising target in the diagnosis and treatment of lung cancer in the future.
28
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2017 · 15K citations · Full text
tRF‐Leu‐CAG promotes cell proliferation and cell cycle in non‐small cell lung cancer
Yang Shao, Qiangling Sun, Xiaomin Liu et al. · Chemical Biology & Drug Design · 2017 · 220 citations · Full text
The tumor suppressor PTEN has a critical role in antiviral innate immunity
Shun Li, Mingzhu Zhu, Ruangang Pan et al. · Nature Immunology · 2015 · 190 citations